Managers

The target for the tech firm’s fifth fund is more than 50% larger than its predecessor.

James Huang, managing partner at KPCB China, has formed Panacea Venture, focusing on early stage healthcare investments globally.

Bain Capital veteran Andrew Balson tells Private Equity International why he focused his fundraising on endowments, foundations and family offices and didn’t offer co-investment opportunities.

The Manchester firm raised £100m for its debut impact fund despite reporting diminished appetite from European LPs in the wake of the Brexit referendum.

We take a closer look at the Nordic firm's recent deal and the vogue for stapled transactions.

Blackstone, Carlyle and TPG share their views on how regulation, diversification and fintech are changing the nature of the industry.